The Happi Podcast

Kenvue’s Colin Pinto, VP, Product Development, Skin Health North America

An update on the latest research at Kenvue and details on Lab to Label, a special formulation education event designed for dermatologists.

Author Image

By: Christine Esposito

Editor-in-Chief

Kenvue’s Colin Pinto, VP, Product Development, Skin Health North America

Happi sat down with Colin Pinto, VP, product development skin health North America, to learn about Kenvue’s R&D philosophy, new research from Neutrogena and Aveeno, and how Kenvue stays connected to the dermatology community in meaningful ways, such as Lab to Label. This unique initiative, held in 2025 with George Washington University (GWU), is designed to provide dermatologists with key insights about formulation of skin care products. It proved to be such a success that the second Lab to Label will be held next month at GWU.

Topics of discussion in this podcast include:

• Lab to Label

• Polymeric cleansing technology

• BEMT

• Kenvue’s approach to R&D

Additional Dermatlogy Connections

In addition to Lab to Label, Kenvue also connects with dermatologists through events like Neutrogena Residents Corner, which was held at American Academy of Dermatology (AAD) Meeting in 2026. This activation is designed to reinforce the brand’s commitment to supporting the next generation of future leaders in dermatology—from medical students to residents and research fellows. At AAD 2026, more than 150 residents attended a Residents Corner with Dr. Kavita Mariwalla and Boards University. The session was designed support resident exam preparation.

Keep up with the story. Subscribe to the Happi free daily
newsletter